Navigation Links
Cantel Medical Corp.'s Medivators Group Gains FDA 510(k) Approval For Its Advantage(TM) Plus Endoscope Reprocessing System
Date:2/27/2009

LITTLE FALLS, N.J., Feb. 27 /PRNewswire-FirstCall/ -- CANTEL MEDICAL CORP. (NYSE: CMN) announced today that the FDA has cleared its Medivators Advantage Plus Endoscope Reprocessing System and new Rapicide(R) PA High Level Disinfectant for sale in the United States. The Advantage Plus System, with its accompanying new chemistry, represents the latest in a long line of "state of the art", innovative reprocessing technologies that Medivators has been delivering to hospitals and stand-alone GI centers for over 20 years.

Andrew Krakauer, Cantel Medical's President stated, "We are very pleased to have broadened our regulatory approvals and can now sell the full Advantage Series in the United States. The Advantage Plus, together with its environmentally friendly Rapicide PA chemistry, brings a new, fully integrated and compliant dimension to busy endoscopy centers and is now available worldwide. We believe that this system should rapidly become the new standard of excellence for safety and efficacy, as well as user friendly operation."

Cantel Medical Corp. is a leading provider of infection prevention and control products in the healthcare market. Our products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens.

For further information, visit the Cantel website at www.cantelmedical.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.


'/>"/>
SOURCE Cantel Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cantel Medical Corp. to Present at the 11th Annual Needham Growth Stock Conference
2. Cantel Medical Reports 72% Increase in Net Income on Record Sales - EPS of $0.20 vs. $0.12 for Quarter Ended October 31, 2008
3. Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its First Quarter Ended October 31, 2008
4. Cantel Medical Corp. to Present at the Oppenheimer & Co. 19th Annual Healthcare Conference
5. Cantel Medical to Relocate Dutch Manufacturing Operations to the United States to Achieve Operating Savings
6. Cantel Medical Corp. and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic
7. Healthcare Tech and the World: A Discussion About the Impact of Medical Automation on Healthcare
8. Kim Kardashian and Tia Carrere Celebrate Premiere of Revolutionary CellCeuticals(R) Biomedical Skin Treatments at Social Hollywood with Founders Dr. Garth Fisher and Paul Scott Premo
9. Fainting Most Common Medical Crisis on Planes
10. Winner Medical Receives European Patent Office Approval for PurCotton(TM) Production Method
11. University of Pittsburgh Medical Center to Manage New Health Center in Cyprus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... , ... June 27, 2017 , ... DrugDev ... is whether they can trust the sponsor to pay them correctly and on time. ... and CROs establish payment strategies that encourage sites to work on their studies. , ...
(Date:6/27/2017)... , ... June 27, 2017 , ... The Congressional Budget ... to repeal and replace the 2010 Patient Protection and Affordable Care Act (ACA), would ... what would be expected under current law. , More than 20 million Americans have ...
(Date:6/27/2017)... ... June 27, 2017 , ... A January 18th article on ... staggering $6.81 billion by the year 2024 according to a new report. The article ... those made from titanium. Los Angeles area clinic Beverly Hills Periodontics & Dental Implant ...
(Date:6/27/2017)... York, NY (PRWEB) , ... June 27, 2017 ... ... and marketing experts to contribute to an upcoming case studies guidebook. This guidebook ... her organization. , This book will include articles, case studies and how-to’s that ...
(Date:6/27/2017)... CT (PRWEB) , ... June 27, 2017 , ... Dr. ... the recent renovation of his practice, Advanced Periodontics and Dental Implant Center of Connecticut. ... increased the administrative and waiting areas. The renovations are intended to improve patient comfort ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... , June 14, 2017  In 2016, ... Creative Startups pitch competition and came away with ... platform is described by Forbes as "entering the life ... Medical Association as teaching "empathy to medical professionals in ... startup was recently named a finalist for the Department ...
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/7/2017)... , June 7, 2017 Endo International plc ... 7, 2017, the Hon. Joseph R. Goodwin , ... West Virginia , entered a case ... Pelvic Repair System Products Liability Litigation (the "MDL") that ... cases to provide expert disclosures on specific causation within ...
Breaking Medicine Technology: